Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 22:6:39386.
doi: 10.1038/srep39386.

Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer

Affiliations

Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer

Toshihiro Tanaka et al. Sci Rep. .

Abstract

We recently reported that the polycomb complex protein Bmi1 is a marker for lingual epithelial stem cells (LESCs), which are involved in the long-term maintenance of lingual epithelial tissue in the physiological state. However, the precise role of LESCs in generating tongue tumors and Bmi1-positive cell lineage dynamics in tongue cancers are unclear. Here, using a mouse model of chemically (4-nitroquinoline-1-oxide: 4-NQO) induced tongue cancer and the multicolor lineage tracing method, we found that each unit of the tumor was generated by a single cell and that the assembly of such cells formed a polyclonal tumor. Although many Bmi1-positive cells within the tongue cancer specimens failed to proliferate, some proliferated continuously and supplied tumor cells to the surrounding area. This process eventually led to the formation of areas derived from single cells after 1-3 months, as determined using the multicolor lineage tracing method, indicating that such cells could serve as cancer stem cells. These results indicate that LESCs could serve as the origin for tongue cancer and that cancer stem cells are present in tongue tumors.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Morphological observations of tongue cancer and histological analysis of normal tongue and tongue cancer model.
(a) Schematic representation of the timing of 4-NQO administration. (b) Morphological observations of normal tongues and tongues of cancer model mice. The red arrow indicates papilloma. The blue arrow indicates invasive carcinoma. (c) H&E staining of normal tongues and the filiform papillae (d) H&E staining of tongue cancer (e) Immunohistochemical staining of tongue cancer for Krt14 and Ki67. Scale bars: (b) 1 mm; (c) 1 mm (left), 100 μm (right); (d) 1 mm (left), 100 μm (right) (e) 100 μm.
Figure 2
Figure 2. Rosa26CreERT2/rbw mice were labeled with tamoxifen and induced by 4-NQO after the induction of tongue cancer.
Schematic representation of the outcome of multi-color lineage tracing in the Rosa26CreERT2/+ tongue cancer model and timing of 4–NQO and tamoxifen treatment. (b,c) Rosa26CreERT2/rbw mice were injected with tamoxifen after inducing tongue cancer and analyzed at the indicated time points (day 1 and day 7). Scale bars: (b) 50 μm (right), 100 μm (left); (c) 50 μm (right), 100 μm (left and middle).
Figure 3
Figure 3. Fate of cells derived from Bmi1-positive cells in tongue cancer.
(a) Schematic representation of the outcome of multi-color lineage tracing in the Bmi1creER/+/Rosa26rbw/+ tongue cancer model. (b,c,d) Bmi1creER/+/Rosa26rbw/+ mice were injected with tamoxifen and analyzed at the indicated time points (day 7, day 14, and day 28). (e) The ratio of single Bmi1-positive cells in the tumor (Bmi1creER/+/Rosa26rbw/+ mice, N = 6; day 7: n = 39 clones, day 14: n = 29 clones, day 28: n = 123 clones). *p < 0.01. Scale bars: (b) 50 μm (left), 100 μm (right); (c) 50 μm (left), 100 μm (right); (d) 100 μm.

Similar articles

Cited by

References

    1. Kamangar F., Dores G. M. & Anderson W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24, 2137–2150 (2006). - PubMed
    1. Leemans C. R., Braakhuis B. J. & Brakenhoff R. H. The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9–22 (2011). - PubMed
    1. Silva P. et al.. Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review. Clin Otolaryngol 32, 337–345 (2007). - PubMed
    1. Petersen P. E. Oral cancer prevention and control–the approach of the World Health Organization. Oral Oncol 45, 454–460 (2009). - PubMed
    1. Ganly I., Patel S. & Shah J. Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer 118, 101–111 (2012). - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources